MiMoCMidwifery Model of Care for Maternal and Neonatal Health in Ethiopia
Continuity of Midwifery care model
+ Standard care model
Other Study
Summary
Study start date: February 24, 2025
Actual date on which the first participant was enrolled.This clinical trial is investigating a new way to provide care for pregnant women in Ethiopia by using the Midwifery Model of Care (MiMoC). Traditionally, maternity care in Ethiopia can be fragmented, with different healthcare providers involved at different stages, making it difficult for women to have a continuous relationship with their caregivers. The study aims to see if having a consistent midwife throughout pregnancy and childbirth, supported by midwife-led birthing centers, improves the health of mothers and their newborns compared to the usual care. This approach could not only enhance health outcomes but also increase satisfaction and trust in the healthcare system, potentially leading to better use of prenatal and postnatal care services. During the study, 1,654 pregnant women will be randomly assigned to either receive care through the MiMoC approach or the standard care. Women in the MiMoC group will have the same midwife throughout their pregnancy and birth, which helps build a supportive relationship. The study will track various health outcomes for mothers and babies, such as birth complications, satisfaction levels, and healthcare usage. Researchers will also look into the costs and overall effectiveness of this model. Data will be collected independently to ensure accuracy, and the results could provide valuable insights for improving maternal and neonatal healthcare in Ethiopia and other similar regions.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.1654 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 18 to 49 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives